Acute Myeloblastic Leukemia with Maturation Latest Advances
Find the Latest Research About Acute Myeloblastic Leukemia with Maturation
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 251 publications
Limited expression of B-cell maturation antigen in acute myeloid leukemia.
Journal: Journal for immunotherapy of cancer
Published: March 02, 2026
A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE-GLM) for Longitudinal Flow Cytometry Maturation Data Analysis.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: February 06, 2026
B -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.
Journal: Journal of the American Society of Nephrology : JASN
Published: December 26, 2025
B cell maturation antigen is a novel target for immunotherapy of acute myeloid leukemia.
Journal: Journal of hematology & oncology
Published: June 25, 2025
Multipurpose RNA maturation factors dysregulate multiple mRNA processing steps simultaneously and provide new therapeutic opportunities.
Journal: RNA biology
Published: June 09, 2025
Orbital Myeloid Sarcoma as the Initial Presentation of Acute Myeloid Leukemia With Maturation in a Pediatric Patient: A Case Report.
Journal: Cureus
Published: May 29, 2025
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response.
Journal: Cancer gene therapy
Published: March 28, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8+ T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients.
Journal: Transplantation and cellular therapy
Published: March 13, 2025
Orbital Myeloid Sarcoma: An Initial Presentation of Acute Myeloid Leukemia With Maturation.
Journal: Cureus
Published: January 16, 2025
28-color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease.
Journal: Cytometry. Part B, Clinical cytometry
Published: November 11, 2024
Last Updated: 09/19/2026